Unknown

Dataset Information

Engineered Multivalent Nanobodies Potently and Broadly Neutralize SARS-CoV-2 Variants.


ABSTRACT: The COVID-19 pandemic continues to be a severe threat to human health, especially due to current and emerging SARS-CoV-2 variants with potential to escape humoral immunity developed after vaccination or infection. The development of broadly neutralizing antibodies that engage evolutionarily conserved epitopes on coronavirus spike proteins represents a promising strategy to improve therapy and prophylaxis against SARS-CoV-2 and variants thereof. Herein, a facile multivalent engineering approach is employed to achieve large synergistic improvements in the neutralizing activity of a SARS-CoV-2 cross-reactive nanobody (VHH-72) initially generated against SARS-CoV. This synergy is epitope specific and is not observed for a second high-affinity nanobody against a non-conserved epitope in the rec

SUBMITTER: Zupancic JM 

PROVIDER: S-EPMC8420545 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature